» Articles » PMID: 24760888

Mutations in HIV-1 Reverse Transcriptase Affect the Errors Made in a Single Cycle of Viral Replication

Overview
Journal J Virol
Date 2014 Apr 25
PMID 24760888
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: The genetic variation in HIV-1 in patients is due to the high rate of viral replication, the high viral load, and the errors made during viral replication. Some of the mutations in reverse transcriptase (RT) that alter the deoxynucleoside triphosphate (dNTP)-binding pocket, including those that confer resistance to nucleoside/nucleotide analogs, affect dNTP selection during replication. The effects of mutations in RT on the spectrum (nature, position, and frequency) of errors made in vivo are poorly understood. We previously determined the mutation rate and the frequency of different types of mutations and identified hot spots for mutations in a lacZα (the α complementing region of lacZ) reporter gene carried by an HIV-1 vector that replicates using wild-type RT. We show here that four mutations (Y115F, M184V, M184I, and Q151M) in the dNTP-binding pocket of RT that had relatively small effects on the overall HIV-1 mutation rate (less than 3-fold compared to the wild type) significantly increased mutations at some specific positions in the lacZα reporter gene. We also show that changes in a sequence that flanks the reporter gene can affect the mutations that arise in the reporter. These data show that changes either in HIV-1 RT or in the sequence of the nucleic acid template can affect the spectrum of mutations made during viral replication. This could, by implication, affect the generation of drug-resistant mutants and immunological-escape mutants in patients.

Importance: RT is the viral enzyme that converts the RNA genome of HIV into DNA. Errors made during replication allow the virus to escape from the host's immune system and to develop resistance to the available anti-HIV drugs. We show that four different mutations in RT which are known to be associated with resistance to anti-RT drugs modestly increased the overall frequency of errors made during viral replication. However, the increased errors were not uniformly distributed; the additional errors occurred at a small number of positions (hot spots). Moreover, some of the RT mutations preferentially affected the nature of the errors that were made (some RT mutations caused an increase in insertion and deletion errors; others caused an increase in substitution errors). We also show that sequence changes in a region adjacent to a target gene can affect the errors made within the target gene.

Citing Articles

Frequently arising ESX-1-associated phase variants influence fitness in the presence of host and antibiotic pressures.

Luna M, Oluoch P, Miao J, Culviner P, Papavinasasundaram K, Jaecklein E mBio. 2025; 16(3):e0376224.

PMID: 39873486 PMC: 11898584. DOI: 10.1128/mbio.03762-24.


Preclinical Evaluation of Long-Acting Emtricitabine Semi-Solid Prodrug Nanoparticle Formulations.

Curley P, Hobson J, Liptrott N, Makarov E, Al-Khouja A, Tatham L Pharmaceutics. 2023; 15(7).

PMID: 37514020 PMC: 10383755. DOI: 10.3390/pharmaceutics15071835.


HIV-Host Cell Interactions.

Masenga S, Mweene B, Luwaya E, Muchaili L, Chona M, Kirabo A Cells. 2023; 12(10.

PMID: 37408185 PMC: 10216808. DOI: 10.3390/cells12101351.


CRISPR/Cas9: a tool to eradicate HIV-1.

Bhowmik R, Chaubey B AIDS Res Ther. 2022; 19(1):58.

PMID: 36457057 PMC: 9713993. DOI: 10.1186/s12981-022-00483-y.


Physiological magnesium concentrations increase fidelity of diverse reverse transcriptases from HIV-1, HIV-2, and foamy virus, but not MuLV or AMV.

Wang R, Belew A, Achuthan V, Sayed N, DeStefano J J Gen Virol. 2021; 102(12).

PMID: 34904939 PMC: 10019084. DOI: 10.1099/jgv.0.001708.


References
1.
Mansky L, Le Rouzic E, Benichou S, Gajary L . Influence of reverse transcriptase variants, drugs, and Vpr on human immunodeficiency virus type 1 mutant frequencies. J Virol. 2003; 77(3):2071-80. PMC: 140916. DOI: 10.1128/jvi.77.3.2071-2080.2003. View

2.
Kulkarni R, Babaoglu K, Lansdon E, Rimsky L, Van Eygen V, Picchio G . The HIV-1 reverse transcriptase M184I mutation enhances the E138K-associated resistance to rilpivirine and decreases viral fitness. J Acquir Immune Defic Syndr. 2011; 59(1):47-54. DOI: 10.1097/QAI.0b013e31823aca74. View

3.
Gao G, Goff S . Replication defect of moloney murine leukemia virus with a mutant reverse transcriptase that can incorporate ribonucleotides and deoxyribonucleotides. J Virol. 1998; 72(7):5905-11. PMC: 110394. DOI: 10.1128/JVI.72.7.5905-5911.1998. View

4.
Matsumi S, Kosalaraksa P, Tsang H, Kavlick M, Harada S, Mitsuya H . Pathways for the emergence of multi-dideoxynucleoside-resistant HIV-1 variants. AIDS. 2003; 17(8):1127-37. DOI: 10.1097/00002030-200305230-00003. View

5.
Mansky L, Pearl D, Gajary L . Combination of drugs and drug-resistant reverse transcriptase results in a multiplicative increase of human immunodeficiency virus type 1 mutant frequencies. J Virol. 2002; 76(18):9253-9. PMC: 136424. DOI: 10.1128/jvi.76.18.9253-9259.2002. View